Serial Number | 79356514 |
Word Mark | CHIRAL CQ QUEST |
Filing Date | Friday, September 2, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 28, 2024 |
Registration Number | 7393974 |
Registration Date | Tuesday, May 28, 2024 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, March 12, 2024 |
Goods and Services | Recycling of chemicals; water treating; cryopreservation services; medicinal materials processing, namely processing of amino acids derivatives, chiral or heterocyclic molecular derivatives; chemical processing |
Description of Mark | The mark consists of the capitalized words "CHIRAL QUEST" with a diamond-shaded figured formed by the letters "C" and "Q" at the center. The left part of the figure is a solid black line, and the right part of the figure is a black and white stripe. |
Pseudo Mark | CHIRAL Q QUEST |
Goods and Services | Medicines for human purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; pharmaceutical preparations for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemico-pharmaceutical preparations for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; drugs for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; biological preparations for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; amino acids for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; active pharmaceutical ingredient, namely amino acids derivatives, chiral or heterocyclic molecular derivatives for medical purposes; chemical reagents for medical or veterinary purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemical preparations for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemical preparations for pharmaceutical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology |
Pseudo Mark | CHIRAL CQ QUEST |
Goods and Services | Hydrochlorates; benzene derivatives being industrial chemicals; p-aminophenol; agricultural chemicals, except fungicides, herbicides, insecticides and parasiticides; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; catalysts for oxidation process; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; catalysts for chemical and biochemical processes |
NOT AVAILABLE | "CHIRAL" |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 2, 2022 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 2, 2022 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 2, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Chiral Quest (Suzhou) Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | CN |
Party Name | Chiral Quest (Suzhou) Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CN |
Party Name | Chiral Quest (Suzhou) Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CN |
Event Date | Event Description |
Thursday, December 1, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, December 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, December 6, 2022 | APPLICATION FILING RECEIPT MAILED |
Tuesday, June 20, 2023 | ASSIGNED TO EXAMINER |
Monday, June 26, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, June 27, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, August 3, 2023 | REFUSAL PROCESSED BY MPU |
Thursday, August 3, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, August 21, 2023 | REFUSAL PROCESSED BY IB |
Monday, January 29, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Monday, January 29, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Monday, January 29, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, January 29, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, January 29, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Monday, January 29, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, January 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, January 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, January 30, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, January 30, 2024 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, January 30, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, January 30, 2024 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, January 30, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, February 21, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, February 21, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Monday, March 11, 2024 | NOTIFICATION PROCESSED BY IB |
Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, May 1, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, May 1, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Tuesday, May 21, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Tuesday, May 28, 2024 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, May 28, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Wednesday, August 28, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |